AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹3,486 Cr | ₹3,173 Cr | ₹1,928 Cr | ₹2,648 Cr | ₹5,335 Cr |
What is the latest Consolidated Net Profit of AUROBINDO PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹3,486 Cr |
| Mar2025 | ₹3,173 Cr |
| Mar2024 | ₹1,928 Cr |
| Mar2023 | ₹2,648 Cr |
| Mar2022 | ₹5,335 Cr |
How is Consolidated Net Profit of AUROBINDO PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,486 Cr | 9.86 | |
| Mar2025 | ₹3,173 Cr | 64.62 | |
| Mar2024 | ₹1,928 Cr | -27.21 | |
| Mar2023 | ₹2,648 Cr | -50.36 | |
| Mar2022 | ₹5,335 Cr | - | |
Compare Consolidated Net Profit of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹97,818.0 Cr | 0.2% | 4.2% | 53.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 0.2% |
4.2% |
53.1% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses